TNKS and breast carcinoma: For the first time, we demonstrated that a combination of Tankyrase inhibitor i.e., XAV939 and a low dose of paclitaxel treatment could be a potential approach for treating TNBC cancer and carcinogen-induced breast cancer with minimum side effects.